Biden’s Drug Cost Cap to Save Average $1,500 Next Year: Analysis
TL/DR -
The Biden administration's cap on the cost of insulin and epinephrine is projected to save Americans with diabetes and severe allergies an average of $1,500 each next year, according to an analysis by the Department of Health and Human Services. The new rule, set to take effect in January 2023, will limit the co-pay for these drugs to $35…